Mavyret: Cost, Side Effects, Dosage, Use for Hep C, and More

Hepatitis C used to be the kind of diagnosis that came with long treatments, big side effects, and enough lab visits to earn you a punch card. Now? Most people can be cured with a short course of once-daily pills. One of the best-known options is Mavyret (glecaprevir/pibrentasvir), a direct-acting antiviral (DAA) that targets hepatitis C virus (HCV) in multiple ways.

This guide breaks down what Mavyret is used for, how dosing works, what side effects to watch for, and how much it can cost in the U.S. We’ll keep it practical, thorough, and just funny enough to make reading about liver enzymes slightly less thrilling than watching paint dry.

Medical note: This article is educational and not medical advice. Only a licensed clinician can recommend the right regimen for you.

Quick Facts: Mavyret at a Glance

• What it is: A fixed-dose combo of glecaprevir (NS3/4A protease inhibitor) + pibrentasvir (NS5A inhibitor).
• What it treats: Acute or chronic HCV genotypes 1–6 in adults and children age 3+ who have no cirrhosis or compensated cirrhosis.
• Typical schedule: Once daily with food.
• Typical duration: Often 8 weeks for treatment-naïve patients (including many with compensated cirrhosis), but longer courses exist for certain situations (prior treatment, transplant, etc.).
• Big safety headline: Risk of hepatitis B reactivationproviders test for current/prior HBV before starting.

What Is Mavyret Used For?

Mavyret is a prescription medication used to treat hepatitis C, a viral infection that can cause liver inflammation, scarring (fibrosis), cirrhosis, liver failure, and liver cancer over time. The goal of treatment is a durable cure, typically confirmed when HCV RNA remains undetectable after therapy (often checked at least 12 weeks after completion).

Who Can Take Mavyret?

In the U.S., Mavyret is approved for adults and pediatric patients (age 3 and older) with HCV genotypes 1–6 who have:

• No cirrhosis, or
• Compensated cirrhosis (Child-Pugh A), meaning the liver is scarred but still doing its job reasonably well.

It may also be used in certain people who have been treated before (for example, some genotype 1 patients previously treated with an NS5A inhibitor or an NS3/4A protease inhibitorthough not both). The details matter here, so don’t DIY your regimen based on a blog post (even a charming one).

Who Should NOT Use Mavyret?

Mavyret is not for everyone. It’s contraindicated in people with:

• Moderate to severe hepatic impairment (Child-Pugh B or C)
• Any history of prior hepatic decompensation (past episodes like ascites, variceal bleeding, hepatic encephalopathy)
• Use with certain meds such as rifampin or atazanavir (more on interactions below)

How Mavyret Works (Without a Virology Lecture)

Hepatitis C needs specific viral tools to copy itself and assemble new virus particles. Mavyret blocks two of them:

• Glecaprevir inhibits the NS3/4A protease (a viral “scissor” used to process proteins the virus needs).
• Pibrentasvir inhibits NS5A (a viral “project manager” involved in replication and assembly).

By blocking two key steps, the medication makes it extremely hard for HCV to keep running its copy-and-paste operation.

Mavyret Dosage and Treatment Duration

Standard Adult Dosage

The recommended adult dosage is 3 tablets taken at the same time once daily with food. That’s a total daily dose of glecaprevir 300 mg and pibrentasvir 120 mg.

Pediatric Dosage

For children age 3 to under 12 who weigh under 45 kg (99 lbs), providers may prescribe oral pellets with weight-based dosing. Kids 12+ (or ≥45 kg) typically use the same 3-tablet daily dose as adults.

How Long Do You Take It?

The duration depends on your clinical situationespecially whether you’re treatment-naïve, whether you have cirrhosis (and what kind), whether you’ve had a transplant, and whether you’ve taken certain hepatitis C meds before.

• Treatment-naïve (many patients): Often 8 weeks, including many patients with no cirrhosis and many with compensated cirrhosis.
• Liver or kidney transplant recipients: Often 12 weeks.
• Some prior-treatment scenarios: May require 16 weeks depending on genotype and what you took previously.

Translation: yes, the “8-week cure” tagline exists for a reason, but your liver’s backstory and medication history still get a vote.

What If You Miss a Dose?

If you miss a dose:

• If it’s less than 18 hours from your usual time, take the dose as soon as possible with food, then take the next dose at the usual time.
• If it’s more than 18 hours, skip the missed dose and take your next dose at the usual time (with food).

Don’t double up unless your clinician explicitly tells you to. Your liver likes consistency, not surprises.

How Effective Is Mavyret for Hep C?

Modern DAA therapy cures hepatitis C in the vast majority of patientsoften above 95%when taken correctly. For Mavyret specifically, clinical trials and real-world data support very high sustained virologic response rates (SVR), which is the lab-based way of saying “virus: gone.”

What Does “Cure” Mean for Hepatitis C?

Clinicians typically confirm cure by checking HCV RNA at least 12 weeks after treatment completion. If HCV RNA remains undetectable at that point (often called SVR12), it’s considered a cure for that infection.

Important fine print: cure does not mean immunity. You can be reinfected if you’re exposed again.

Mavyret Side Effects: Common, Less Common, and Serious

Most people tolerate Mavyret well, but “well tolerated” doesn’t mean “you’ll feel like a Disney prince/princess singing with birds.” It means side effects are usually manageable and temporary.

Common Side Effects

• Headache
• Fatigue (the “I could nap in a meeting” vibe)
• Nausea
• Diarrhea (more common in some populations)
• Itching (pruritus) (not everyone, but it’s a known guest)

Serious Risks to Know About

• Hepatitis B reactivation: People with current or prior HBV infection can experience HBV reactivation during or after DAA therapy. That’s why HBV testing happens before starting, and why monitoring may continue.
• Liver problems in people with advanced liver disease: Rare cases of hepatic decompensation or failure have been reported, especially in patients who already had significant liver impairment or prior decompensation.
• Severe allergic reactions: Uncommon, but any swelling of the face/lips/tongue, severe rash, or trouble breathing needs urgent care.

When to Call a Clinician Right Away

Seek medical advice promptly if you notice symptoms such as yellowing of skin/eyes, dark urine, severe abdominal swelling, confusion, vomiting blood (or material that looks like coffee grounds), or black/bloody stools.

Warnings and Precautions (The Part You Shouldn’t Skip)

1) Hepatitis B Screening Is Not Optional

Before starting Mavyret, clinicians test for evidence of current or prior hepatitis B infection (commonly HBsAg and anti-HBc), and they monitor appropriately if you’re at risk. This is standard safety practice with DAAs.

2) Cirrhosis Status MattersA Lot

“Cirrhosis” isn’t just one checkbox. The key distinction is:

• Compensated cirrhosis (Child-Pugh A): May still be eligible for Mavyret in many cases.
• Decompensated cirrhosis (Child-Pugh B/C) or prior decompensation: Not eligible for Mavyret.

3) Pregnancy and Breastfeeding

There aren’t adequate human data to fully define risk in pregnancy, so decisions should be individualized with a clinician. If pregnancy is possible, ask your prescriber what testing and contraception guidance makes sense for your situation.

Drug Interactions: Where Most “Oops” Moments Happen

Mavyret has important interactions because it’s processed through liver transporters and enzymes that other drugs can influence. Always give your clinician a full medication list, including supplements.

Notable Interactions (Examples)

• Rifampin: contraindicated (can reduce Mavyret levels and effectiveness).
• Atazanavir: contraindicated (can raise levels and increase ALT elevation risk).
• Carbamazepine, efavirenz, St. John’s wort: not recommended (can reduce Mavyret effectiveness).
• Ethinyl estradiol > 20 mcg (some combined oral contraceptives): not recommended due to risk of ALT elevations. (Progestin-only options may be acceptableyour prescriber can guide you.)
• Statins (e.g., atorvastatin, simvastatin, lovastatin): may require avoidance or dose limits due to myopathy/rhabdomyolysis risk.
• Cyclosporine: higher stable doses may be problematic; careful management is required.
• Dabigatran, digoxin: monitoring/dose adjustments may be needed depending on the situation.

Real-life tip: bring your medication bottles (or a screenshot list) to appointments. Your memory is great, but it’s not FDA-labeled.

Mavyret Cost in the U.S.: What You Might Pay and Why It Varies So Much

Let’s talk money, because hepatitis C treatment shouldn’t require a second mortgage and a third job. Unfortunately, pricing for branded DAAs can be complicated.

List Price vs. Real-World Price

The Wholesale Acquisition Cost (WAC)often called the “list price”for one month of Mavyret has been reported as $13,200 (as of January 2025). But many people do not pay that amount out of pocket due to insurance negotiations, rebates, pharmacy benefit structures, and assistance programs.

Example: Estimating the Medication Cost for an 8-Week Course

An 8-week course is about two months of therapy. Using the WAC figure as a simple reference point (not a promise), two months would be about $26,400. In reality, what a patient pays can range from “small copay” to “please sit down” depending on:

• Your insurance type (commercial, Medicare/Medicaid, none)
• Deductible status (met it yet, or still wrestling it?)
• Formulary coverage and prior authorization requirements
• Pharmacy network rules (specialty pharmacy vs. retail)
• Eligibility for copay cards or patient assistance

Ways People Reduce Out-of-Pocket Costs

• Manufacturer savings card (commercial insurance): Some eligible patients with commercial insurance may pay as little as $5 per month through the program terms.
• Patient assistance programs: For uninsured or underinsured patients who qualify by income and other criteria, manufacturer assistance programs may provide medication at reduced or no cost.
• Discount programs and price comparison tools: Cash prices can vary dramatically by pharmacy and location. These tools can also be useful for people in coverage gaps.
• Clinic support: Many hepatology, GI, infectious disease, and community clinics have staff who handle prior authorizations and appeals. (Shoutout to the unsung heroes of fax machines everywhere.)

Using Mavyret for Hep C: What Treatment Usually Looks Like

While each patient plan is personalized, most treatment journeys include:

1. Confirmation of infection (HCV RNA testing), plus baseline assessment including liver status.
2. Screening for hepatitis B (and often HIV), plus a medication interaction review.
3. Starting therapy with clear instructions: take all tablets together once daily with food.
4. Support during treatment: checking in about side effects, new meds, adherence, and red flags.
5. Test of cure: HCV RNA checked about 12 weeks after treatment completion to confirm SVR12.

Do You Need Genotype Testing?

In many settings, simplified pathways may allow treatment without extensive pre-testing for genotype, because Mavyret is pangenotypic (covers genotypes 1–6). But clinicians still evaluate liver status carefully, and certain clinical histories may require additional testing before choosing a regimen.

Frequently Asked Questions

Can I drink alcohol while taking Mavyret?

There isn’t a “Mavyret + alcohol” cocktail that earns a gold star. Many clinicians recommend avoiding alcohol during hepatitis C treatment because alcohol can worsen liver inflammation and slow liver healing. If you drink, ask your clinician for individualized guidance.

What if I feel tiredshould I stop the medication?

Fatigue can happen, but stopping early can reduce your chance of cure. If fatigue is severe or comes with concerning symptoms (like jaundice, confusion, or swelling), contact a clinician promptly.

Will Mavyret cure my hepatitis C permanently?

If you achieve SVR12, the infection is considered cured. However, you can be reinfected after new exposure. Prevention and harm-reduction strategies still matter.

What the Mavyret Experience Feels Like (500+ Words)

Let’s talk about the part people actually live through: the day-to-day experience of taking Mavyret. Not the glossy brochure version. The real versionwhere you still have a job, a family, a phone with 97 notifications, and a liver that would prefer you keep things boring.

Week 0 (the “paperwork Olympics”): For many patients, the first challenge isn’t swallowing pillsit’s getting them. Because DAAs are specialty meds, pharmacies and insurers often require prior authorization. This can mean your clinician submits lab results, liver staging info, and documentation that Mavyret is appropriate. Some people are approved quickly; others get the dreaded “more information needed,” which is healthcare’s version of “we’ll circle back.” The good news is that many clinics handle this routinely, and manufacturer support programs may help with coverage navigation and savings options.

Week 1 (the “new routine” phase): Mavyret is taken once daily, but it’s three tablets at the same time, and it must be taken with food. People commonly pick a consistent anchorbreakfast or dinnerbecause consistency helps prevent missed doses. If you’re the type who forgets water is a beverage, setting a daily alarm is not a moral failure; it’s strategy. Some patients say the easiest move is pairing the dose with something you already do every day (coffee, lunch, feeding the dog). The dog will remember even if you don’t.

Side effects in real life: Many patients report little to no disruption. When side effects do show up, the most typical are fatigue, headache, and mild nauseathings that can feel annoyingly non-specific. “Am I tired because of Mavyret or because I’m an adult?” is a surprisingly fair question. People often find that hydration, regular meals, and sleep consistency help. If nausea pops up, taking the dose with a solid meal (not just a single cracker performing as “food”) can make a difference.

Weeks 2–6 (the “life continues” stretch): This is often the easiest part: the medication becomes normal, the routine is set, and the body adapts. A lot of patients describe a psychological shift hereless fear, more “wait, this is actually manageable.” Some people feel a gradual improvement in energy or mental clarity as viral levels drop, though experiences vary widely. The big focus is adherence: taking it daily, avoiding interacting medications or supplements, and checking in with the clinician if anything changes. It’s also common for clinicians to remind patients not to start new meds (including herbal supplements) without asking, because interactions can matter.

Finish line (end of treatment): Completing therapy can feel anticlimactic in the best waylike finishing a book where the villain simply leaves town. But there’s usually one more important step: the test of cure. Many patients feel anxious waiting for the SVR12 lab result. That’s normal. If your clinician schedules labs 12 weeks after completion, it’s not because they like paperworkit’s because undetectable HCV RNA at that point is the standard marker of cure.

After cure (the “now what?” moment): People without cirrhosis who achieve SVR often don’t need liver-focused follow-up. Patients with advanced scarring may still need monitoring for liver complications even after cure (because cirrhosis doesn’t vanish overnight). Many patients describe a mix of relief and motivation: relief that hepatitis C is treatable, and motivation to protect their liver going forward. The most common advice patients say they wish they heard earlier is simple: stay consistent, communicate early about side effects or new meds, and remember that cure is the expectationnot a miracle.

Conclusion

Mavyret is one of the most widely used pangenotypic hepatitis C treatments in the U.S., combining high cure rates with a short, once-daily regimen. The key takeaways are straightforward: take it exactly as prescribed (with food), don’t ignore drug interactions, get screened for hepatitis B, and follow through with the test-of-cure lab work after treatment.

If cost is your biggest barrier, you’re not aloneand you’re not out of options. Insurance coverage, savings programs, and patient assistance pathways can dramatically reduce out-of-pocket costs. Talk with your clinician’s office and pharmacy team; they deal with these hurdles every day.